John Borgeson compensation by year
Kodiak Sciences Summary Compensation Table · all 9 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Salary | $297,250 | $327,218 | $401,500 | $425,500 | $453,000 | $475,000 | $497,125 | $525,025 | $552,968 |
| Bonus | $168,345 | $180,000 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $889,471 | $783,441 | $1,323,150 | $0 | $0 | $0 | $0 |
| Option awards | $0 | $1,605,320 | $4,697,833 | $1,460,547 | $25,844,150 | $839,981 | $959,210 | $559,920 | $678,700 |
| Non-equity incentive | $0 | $0 | $224,879 | $255,351 | $241,200 | $181,719 | $212,564 | $259,930 | $373,321 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $9,500 | $11,768 | $10,302 | $10,802 | $10,802 | $10,844 | $10,868 |
| Total | $465,595 | $2,112,538 | $6,223,183 | $2,936,607 | $27,871,802 | $1,507,502 | $1,679,701 | $1,355,719 | $1,615,857 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Kodiak Sciences Inc. DEF 14A filed April 22, 2026, accession 0001193125-26-170429, and prior-year filings.
How this page was built: the Kodiak Sciences Inc. filed document, accession 0001193125-26-170429. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 500,000 | — | $88.21 |
| Option | 20,782 | — | $8.15 |
| Option | 216,032 | — | $2.49 |
| Option | 223,959 | — | $3.95 |
| Option | 82,136 | — | $7.24 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Kodiak Sciences Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
15 Form 4 lines since the FY2025 proxy (filed April 22, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-10-21 | Exercise or conversion | 10b5-1 | 30,000 | $2.49 | 241,930 |
| 2026-10-21 | Sale | 10b5-1 | 100 | $94.91 | 211,930 |
| 2026-10-21 | Sale | 10b5-1 | 5,101 | $90.98 | 219,015 |
| 2026-10-21 | Sale | 10b5-1 | 2,985 | $91.76 | 216,030 |
| 2026-10-21 | Sale | 10b5-1 | 2,000 | $92.66 | 214,030 |
| 2026-10-21 | Sale | 10b5-1 | 2,000 | $93.71 | 212,030 |
| 2026-10-21 | Exercise or conversion derivative | 10b5-1 | 30,000 | $0.00 | 304,500 |
| 2026-10-21 | Sale | 10b5-1 | 8,514 | $87.67 | 233,416 |
The 8 most recent of 15 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Kodiak Sciences’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Victor Perlroth | Chief Executive Officer and Chairman of the Board | $2,499,221 |
| John Borgeson · this page | Executive Vice President, Chief Financial Officer and Secretary | $1,615,857 |
John Borgeson's compensation dossier, Kodiak Sciences
You have read John Borgeson's totals and holdings. The dossier adds each equity grant Kodiak Sciences disclosed for John Borgeson and Kodiak Sciences's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Kodiak Sciences compensation record
free company briefThis page is one person within Kodiak Sciences's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Kodiak Sciences proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Kodiak Sciences's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Kodiak Sciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.